Hou et al. found that (Hou et al., 2020) IgM levels in COVID-19 patients with severe and critical disease were higher than those in patients with mild disease, while IgG levels in patients with critical disease were lower than those in patients with mild and severe disease. Here, CD40LG is linked to COVID-19.